Viatris (VTRS) Interest Expenses (2019 - 2026)

Viatris' (VTRS) quarterly Interest Expenses came in at $1.2 billion in Q1 2026, down 2.19% year-on-year from $1.2 billion in Q1 2025, and up 908.36% quarter-over-quarter from $119.6 million in Q4 2025.

Viatris (VTRS) Interest Expenses (2019 - 2026) Analysis & Trends

Viatris' Interest Expenses history runs 8 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

  • On a quarterly basis, Interest Expenses fell 2.19% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 2.19% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 16.75% from the prior year.
  • Interest Expenses grew to $1.2 billion in Q1 2026 per VTRS's latest filing, from $119.6 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $2.1 billion in Q1 2022 and bottomed at $119.6 million in Q3 2025.
  • The 5-year median for Interest Expenses is $147.1 million (2022), against an average of $874.5 million.
  • Across the five-year window, Interest Expenses sank 93.15% in 2023 and soared 747.05% in 2025, its largest moves.
  • Year by year, Interest Expenses stood at $147.1 million in 2022, then retreated by 4.21% to $140.9 million in 2023, then dropped by 14.69% to $120.2 million in 2024, then retreated by 0.5% to $119.6 million in 2025, then jumped by 908.36% to $1.2 billion in 2026.
  • Per Business Quant, the three latest VTRS Interest Expenses figures stand at $1.2 billion (Q1 2026), $119.6 million (Q4 2025), and $119.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 944.51 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.77 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 2.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.21 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 590.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 258.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.21 Bn
Mar 31, 2026 1.21 Bn
Dec 31, 2025 119.60 Mn
Dec 31, 2025 119.60 Mn
Sep 30, 2025 119.60 Mn
Sep 30, 2025 119.60 Mn
Jun 30, 2025 1.24 Bn
Jun 30, 2025 1.24 Bn
Mar 31, 2025 1.23 Bn
Mar 31, 2025 1.23 Bn
Dec 31, 2024 120.20 Mn
Dec 31, 2024 120.20 Mn
Sep 30, 2024 145.60 Mn
Sep 30, 2024 145.60 Mn
Jun 30, 2024 145.80 Mn
Jun 30, 2024 145.80 Mn
Mar 31, 2024 1.77 Bn
Mar 31, 2024 1.77 Bn
Dec 31, 2023 140.90 Mn
Dec 31, 2023 140.90 Mn